Case Report: Disposition of Symptomatic Probable COVID-19

Jaffery, Aleq; Slakey, John; Zodda, David; Finefrock, Douglas

doi:10.5811/cpcem.2020.5.48318

Cited by 1 publication

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Previous studies have reported that monitoring of outpatients with COVID-19 is effective in identifying patients with alarming symptomatology. Remote follow-up of ambulatory patients has been evaluated during the acute phase of illness, both in adult ( 3 ) and pediatric patients ( 4 ) with mild SARS-CoV-2 infection after being discharged from the hospital and in some patients with pneumonia even with moderate risk of progression to acute respiratory distress ( 12 ), and remote monitoring has been associated with a reduction in hospital readmission ( 13 ). However, a systematic review of remote monitoring concluded that the real effectiveness of the different interventions could not be determined reliably.…”

Section: Discussionmentioning

confidence: 99%

A Multimodal Strategy to Reduce the Risk of Hospitalization/death in Ambulatory Patients with COVID-19

Ascencio-Montiel

Tomás-López

Álvarez-Medina

et al. 2022

Archives of Medical Research

View full text Add to dashboard Cite

Background Different interventions have been implemented worldwide for the house-hold monitoring of patients with mild COVID-19 to reduce the burden of healthcare systems and guarantee quality of care. Telephone follow up and treatment kits have not been evaluated in the context of a national-wide primary care program. Aim of the study To compare the risk of hospitalization and death for COVID-19 between ambulatory patients who received and those who did not receive a treatment kit and telephone follow-up in a developing country Methods A two-group comparative analysis was conducted using data from the medical information systems of the Mexican Institute of Social Security. We included a total of 28,048 laboratory-confirmed SARS-CoV-2 patients: 7,898 (28.2%) received a medical kit and 20,150 (71.8%) did not. The incidence rates of hospitalization and death combined were calculated. To identify significant associations between hospitalization or death and treatment medical kits, we calculated the risk ratios using a multivariate logistic model. Results The incidence of hospitalization was 6.14% in patients who received a kit and 11.71% in those who did not. Male sex, age, and a medical history of obesity, hypertension, diabetes, immunosuppression, or kidney disease were associated with increased risk of hospitalization or death. The risk rates were reduced in patients who received a medical kit or telephone follow-up. In the multivariate model, receiving a medical kit was associated with a lower risk of hospitalization or death from COVID-19: adjusted risk ratio 0.35 (95% confidence interval 0.30–0.40). Conclusion Use of a multimodal strategy may reduce the risk of hospitalization and death in adult outpatients with mild COVID-19.

show abstract

Section: Discussionmentioning

confidence: 99%